Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1984 11
1985 3
1991 1
1994 1
1995 1
1997 1
1998 1
2000 1
2001 1
2003 3
2004 6
2005 2
2006 5
2007 7
2008 5
2009 9
2010 13
2011 21
2012 18
2013 12
2014 18
2015 14
2016 12
2017 10
2018 12
2019 9
2020 4
2021 20
2022 20
Text availability
Article attribute
Article type
Publication date

Search Results

218 results
Results by year
Filters applied: . Clear all
Page 1
An inhibitor of oxidative phosphorylation exploits cancer vulnerability.
Molina JR, Sun Y, Protopopova M, Gera S, Bandi M, Bristow C, McAfoos T, Morlacchi P, Ackroyd J, Agip AA, Al-Atrash G, Asara J, Bardenhagen J, Carrillo CC, Carroll C, Chang E, Ciurea S, Cross JB, Czako B, Deem A, Daver N, de Groot JF, Dong JW, Feng N, Gao G, Gay J, Do MG, Greer J, Giuliani V, Han J, Han L, Henry VK, Hirst J, Huang S, Jiang Y, Kang Z, Khor T, Konoplev S, Lin YH, Liu G, Lodi A, Lofton T, Ma H, Mahendra M, Matre P, Mullinax R, Peoples M, Petrocchi A, Rodriguez-Canale J, Serreli R, Shi T, Smith M, Tabe Y, Theroff J, Tiziani S, Xu Q, Zhang Q, Muller F, DePinho RA, Toniatti C, Draetta GF, Heffernan TP, Konopleva M, Jones P, Di Francesco ME, Marszalek JR. Molina JR, et al. Among authors: tabe y. Nat Med. 2018 Jul;24(7):1036-1046. doi: 10.1038/s41591-018-0052-4. Epub 2018 Jun 11. Nat Med. 2018. PMID: 29892070
Exogenous mitochondrial transfer and endogenous mitochondrial fission facilitate AML resistance to OxPhos inhibition.
Saito K, Zhang Q, Yang H, Yamatani K, Ai T, Ruvolo V, Baran N, Cai T, Ma H, Jacamo R, Kuruvilla V, Imoto J, Kinjo S, Ikeo K, Moriya K, Suzuki K, Miida T, Kim YM, Vellano CP, Andreeff M, Marszalek JR, Tabe Y, Konopleva M. Saito K, et al. Among authors: tabe y. Blood Adv. 2021 Oct 26;5(20):4233-4255. doi: 10.1182/bloodadvances.2020003661. Blood Adv. 2021. PMID: 34507353 Free PMC article.
Break the lifeline of AML cells.
Tabe Y, Konopleva M. Tabe Y, et al. Blood. 2021 Jun 24;137(25):3465-3467. doi: 10.1182/blood.2021011475. Blood. 2021. PMID: 34165546 Free article. No abstract available.
[Epigenetics].
Tabe Y. Tabe Y. Nihon Rinsho. 2012 Apr;70 Suppl 2:86-90. Nihon Rinsho. 2012. PMID: 23133933 Japanese. No abstract available.
Fatty Acid Metabolism, Bone Marrow Adipocytes, and AML.
Tabe Y, Konopleva M, Andreeff M. Tabe Y, et al. Front Oncol. 2020 Feb 18;10:155. doi: 10.3389/fonc.2020.00155. eCollection 2020. Front Oncol. 2020. PMID: 32133293 Free PMC article. Review.
Leukemia Stem Cells Microenvironment.
Tabe Y, Konopleva M. Tabe Y, et al. Adv Exp Med Biol. 2017;1041:19-32. doi: 10.1007/978-3-319-69194-7_3. Adv Exp Med Biol. 2017. PMID: 29204827
Inhibition of BCL2A1 by STAT5 inactivation overcomes resistance to targeted therapies of FLT3-ITD/D835 mutant AML.
Yamatani K, Ai T, Saito K, Suzuki K, Hori A, Kinjo S, Ikeo K, Ruvolo V, Zhang W, Mak PY, Kaczkowski B, Harada H, Katayama K, Sugimoto Y, Myslinski J, Hato T, Miida T, Konopleva M, Hayashizaki Y, Carter BZ, Tabe Y, Andreeff M. Yamatani K, et al. Among authors: tabe y. Transl Oncol. 2022 Apr;18:101354. doi: 10.1016/j.tranon.2022.101354. Epub 2022 Feb 1. Transl Oncol. 2022. PMID: 35114569 Free PMC article.
218 results